Imeglimin improves hyperglycemia and hypoglycemia‐induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells
Journal of Diabetes Investigation · 2025
DOI: 10.1111/jdi.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Ayako Kato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Schwann Cells, Mitochondria, Hyperglycemia, Cell Death. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims/Introduction Imeglimin, a novel oral antidiabetic drug, enhances glucose‐stimulated insulin secretion, improves insulin sensitivity, and reduces mitochondrial reactive oxygen species (ROS) generation. Diabetic neuropathy is driven by oxidative stress caused by hyperglycemia, with mitochondrial ROS overproduction playing a central role. Hypoglycemia also contributes to oxidative stress. This study evaluates the effects of imeglimin on Schwann cells under high‐ and low‐glucose conditions. Materials and Methods We used IMS32 cells, an immortalized mouse Schwann cell line, to investigate cell survival and mitochondrial function under normal, high‐, and low‐glucose conditions. Assessments included mitochondrial oxidative stress, cytochrome c release, mitochondrial membrane potential, oxygen consumption rate (OCR), Complex I activity, and ATP synthesis.
Results
High‐ and low‐glucose conditions caused cell death, elevated mitochondrial ROS, triggered cytochrome c release, disrupted mitochondrial membrane potential, and increased OCR and Complex I activity, while suppressing ATP synthesis. Imeglimin treatment mitigated cell death, reduced oxidative stress, restored mitochondrial membrane potential, normalized OCR and Complex I activity, and improved ATP synthesis under both glucose conditions.
Conclusions
Fluctuations in glucose levels impair mitochondrial function in Schwann cells, contributing to peripheral nerve damage in diabetic neuropathy. Imeglimin demonstrated protective effects by alleviating mitochondrial dysfunction and preventing apoptosis signaling. These findings suggest the potential application of imeglimin in preventing and treating diabetic neuropathy; however, the clinical implications require further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan.
- Diabetic Neuropathy Project, Department of Sensory and Motor Systems, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
- Laboratory of Molecular Neuroscience and Neurology, Tokyo University of Pharmacy & Life Science, Hachioji, Tokyo, Japan.
- Laboratory of Medical Biochemistry, Toho University School of Pharmacy, Funabashi, Chiba, Japan.
- Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
ORCID-Profile: Ayako Kato, Masaki Kondo, Jiro Nakamura, Hideki Kamiya, Kazunori Sango, Koichi Kato
Zitieren
APA
Kato, A., Nihei, W., Yako, H., Tatsumi, Y., Himeno, T., Kondo, M., Kato, Y., Nakamura, J., Kamiya, H., Sango, K., & Kato, K. (2025). Imeglimin improves hyperglycemia and hypoglycemia‐induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70092
Vancouver
Kato A, Nihei W, Yako H, Tatsumi Y, Himeno T, Kondo M, et al. Imeglimin improves hyperglycemia and hypoglycemia‐induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70092
BibTeX
@article{Kato2025,
author = {Kato, Ayako and Nihei, Wataru and Yako, Hideji and Tatsumi, Yasuaki and Himeno, Tatsuhito and Kondo, Masaki and Kato, Yoshiro and Nakamura, Jiro and Kamiya, Hideki and Sango, Kazunori and Kato, Koichi},
title = {Imeglimin improves hyperglycemia and hypoglycemia‐induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells},
journal = {Journal of Diabetes Investigation},
year = {2025},
doi = {10.1111/jdi.70092}
}
EUVIMED